# 3Daughters

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/3daughters

- Industry: Medical Devices & Equipment
- Headquarters: Mansfield, US
- Website: www.3daughtershealth.com
- Total disclosed funding: $6.4M
- Latest round: Seed (Jul 11, 2024)
- Investors on record: 4

## About

Established in 2021 and based in Massachusetts, US, 3Daughters, Inc. operates as a provider of healthcare technology that provides intrauterine devices (IUDs) for contraception to provide personalized therapy directly into the uterus. The company was co-founded by Mary Beth Cicero (CEO) and Shelley Amster. In January 2024, 3Daughters, Inc. raised USD 2 million in seed funding led by investor Thairm Bio, with participation from other investors Argosy Capital, Wexford SciTech Venture Fund, and the University of Massachusetts Amherst (UMass). 

The company focuses on developing a frameless, magnetic intrauterine device (IUD) for contraception. The company's primary product is an innovative IUD designed to be more adaptable to a woman's body. Additionally, the company is exploring the potential use of their technology for targeted therapy in conditions such as fibroids and abnormal bleeding.

## Funding rounds

- Seed, Jul 11, 2024, $2.9M — University of Massachusetts Amherst (UMass), Argosy Healthcare Partners, Thairm Bio, Wexford SciTech Venture Fund
- Seed, Dec 18, 2023, $3.5M — University of Massachusetts Amherst (UMass), Argosy Healthcare Partners, Thairm Bio, Wexford SciTech Venture Fund

## Investors

- University of Massachusetts Amherst (UMass) — Seed
- Argosy Healthcare Partners (https://capitalatlas.ai/funds/argosy-healthcare-partners) — Seed
- Thairm Bio — Seed
- Wexford SciTech Venture Fund (https://capitalatlas.ai/funds/wexford-scitech-venture-fund) — Seed